Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area stem cell stem gsk 3'

Search results for: 'research area stem cell stem gsk 3'

Items 61-70 of 361

Page
per page
  1. SNS-032 (BMS-387032)
    A1980 SNS-032 (BMS-387032)
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK inhibitor
      insoluble in H2O; ≥19.05 mg/mL
  2. PHA-793887
    A5459 PHA-793887
     1 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Pan-Cdk inhibitor
      insoluble in H2O; ≥18.05 mg/mL
  3. LY2835219
    A1794 LY2835219
    Target: Cyclin-Dependent Kinases
    Summary: CDK4/6 inhibitor,potent and selective
      ≥30.15 mg/mL
  4. PD 0332991 (Palbociclib) HCl
    A8316 PD 0332991 (Palbociclib) HCl
     5 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK4/6 inhibitor,highly selective
      ≥14.48 mg/mL
  5. PHA-848125
    A8501 PHA-848125
    Target: Cyclin-Dependent Kinases
    Summary: CDK inhibitor,potent and ATP-competitive
      ≥23.05 mg/mL
  6. BMS265246
    A8385 BMS265246
    Target: Cyclin-Dependent Kinases
    Summary: CDK1/2 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥17.25 mg/mL
  7. Rigosertib sodium salt
    A1404 Rigosertib sodium salt
     1 Citation
    Target: PLK
    Summary: Plk1 inhibitor
      ≥23.65 mg/mL
  8. SB 203580 hydrochloride
    B1285 SB 203580 hydrochloride
    Target: p38
    Summary: Specific p38-MAPKs inhibitor
      insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL
  9. GlyH-101
    B1087 GlyH-101
    Target: CFTR
    Summary: CFTR Inhibitor II
      insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL
  10. Cucurbitacin E
    N2791 Cucurbitacin E
    Target: Actin
    Summary: inhibits actin depolymerization
      insoluble in EtOH; insoluble in H2O; ≥10.2 mg/mL

Items 61-70 of 361

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 342item
  2. Natural Products 2item
  3. Kits 2item
  4. Peptides 1 item
  5. Cell Biology 2item
  6. Peptides & Proteins 1 item
  7. Lab Reagents 7item
Reversibility
  1. Reversible 27item
  2. Irreversible 12item
Target
  1. Caspases 8item
  2. Cyclin-Dependent Kinases 16item
  3. Proteasome 4item
  4. Cathepsins 2item
  5. Histone Deacetylases (HDACs) 13item
  6. Inhibitor of apoptosis proteins (IAP) 2item
  7. Akt 3item
  8. Bcl-2 2item
  9. PI3K 14item
  10. CXCR 2item
  11. Raf 3item
  12. Aurora Kinases 8item
  13. Bcl-xl 1 item
  14. Glycoproteins 1 item
  15. MDM2 2item
  16. EZH2 4item
  17. mTOR 3item
  18. AP-1 2item
  19. MMP 4item
  20. Peptidylprolyl isomerases 1 item
  21. Myosin II ATPases 1 item
  22. DT-diaphorases 1 item
  23. MER 1 item
  24. FLT3 7item
  25. GSK-3 9item
  26. Factor Xa 1 item
  27. LPA Receptors 1 item
  28. P-glycoprotein (P-gp) 5item
  29. PLK 4item
  30. Chk 5item
  31. ULK1 1 item
  32. VEGFR 12item
  33. PDGFR 11item
  34. c-Kit 5item
  35. RET 2item
  36. Bromodomain-containing proteins(BRDs) 1 item
  37. Phosphodiesterases (PDEs) 2item
  38. Mcl-1 1 item
  39. Hydrolase 1 item
  40. p38 4item
  41. PKB 1 item
  42. 3-phosphoglycerate dehydrogenase 1 item
  43. JNK 1 item
  44. SGK 2item
  45. Bcr-Abl 3item
  46. Kynurenine-3-monooxygenase 1 item
  47. MEK 6item
  48. PORCN 1 item
  49. DOT1L 1 item
  50. FGFR 4item
  51. Nrf2 1 item
  52. Pim 1 item
  53. Liver X receptors (LXRs) 1 item
  54. Glucagon-like peptide 1 (GLP-1) receptors 2item
  55. Voltage-gated Sodium (NaV) Channels 1 item
  56. Deubiquitinating enzymes (DUBs) 2item
  57. PP1 1 item
  58. PP2A 1 item
  59. Smoothened 3item
  60. MET 2item
  61. Ras 1 item
  62. Src 4item
  63. Trk Receptors 3item
  64. Aminopeptidases 1 item
  65. STAT 3item
  66. Microtubules/Tubulins 5item
  67. Estrogen and Related Receptors 1 item
  68. EGFR 5item
  69. Hedgehog 1 item
  70. Reverse Transcriptases 1 item
  71. ROCK 5item
  72. RIP kinases 1 item
  73. Monocyte chemotactic proteins 1 item
  74. PAK 1 item
  75. BMP and Other Activin Receptors 1 item
  76. JAK 4item
  77. p300 1 item
  78. Syk 1 item
  79. Progesterone Receptors 1 item
  80. DNA-PK 1 item
  81. HSP90 3item
  82. AMPK 3item
  83. CFTR 3item
  84. TNKS 1 item
  85. Topoisomerases 3item
  86. Renin 1 item
  87. HIV proteases 1 item
  88. Pepsins 1 item
  89. ErbB 2item
  90. Toll-like receptors (TLRs) 3item
  91. Actin 1 item
  92. DNA Methyltransferases 1 item
  93. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  94. ERK 2item
  95. HMG-CoA Reductases 1 item
  96. c-MET 2item
  97. BMI-1 1 item
  98. PKC 1 item
  99. Calpains 1 item
  100. Ca2 /calmodulin-dependent protein kinases (CaMKs) 4item
  101. Lyn 1 item
  102. SGLT 1 item
  103. HER2 1 item
  104. USP 3item
  105. 5-HT2 Receptors 1 item
  106. LRRK2 2item
  107. DGAT 1 item
  108. PARP 1 item
  109. ALK 1 item
  110. Sphingosine kinases (SphKs) 1 item
  111. GTPases 1 item
  112. CETP 1 item
  113. BCPCF efflux 1 item
  114. D2 Receptors 1 item
  115. 5-HT1 Receptors 1 item
  116. 5-HT7 Receptors 1 item
  117. CaM-KK 1 item
  118. AdipoR1 1 item
  119. AdipoR2 1 item
  120. Serotonin reuptake 1 item
  121. Insulin-like growth factors (IGFs) 1 item
  122. NUAK1 1 item
  123. CSF1R 1 item
  124. NUAK2 1 item
  125. Lactate Dehydrogenases (LDH) 1 item
  126. MK2 3item
  127. Fatty-acid-binding proteins (FABPs) 1 item
  128. 5-HT3 Receptors 1 item
  129. Angiotensin-Converting Enzymes (ACEs) 1 item
  130. Tie-2 1 item
  131. Granzyme B 1 item
  132. Free Fatty Acid Receptors 2item
  133. phosphatases 1 item
  134. Autophagy 2item
  135. ATM/ATR 3item
  136. COX 1 item
  137. CK1 1 item
  138. IDH2 1 item
  139. Histamine H4 Receptors 2item
  140. Farnesyl Diphosphate Synthases 1 item
  141. HIV Integrases 2item
  142. Melatonin Receptors 2item
  143. Peroxynitrite 1 item
  144. P2X Receptors 1 item
  145. Ron 1 item
  146. AP endonucleases 1 item
  147. Calcium-activated chloride channels (CaCC) 1 item
  148. GPR35 1 item
  149. MAGL 2item
  150. NPY Receptors 1 item
  151. c-Fyn 1 item
  152. TAK1 1 item
  153. Histamine H1 Receptors 3item
  154. Na /K ATPases 1 item
  155. iNOS 1 item
  156. Histamine H2 Receptors 1 item
  157. Phospholipases 1 item
  158. TRP Channel 1 item
  159. Apoptosis Inducers 1 item
  160. NO Donors / Precursors 1 item
  161. Glucocorticoid Receptors 2item
  162. IL Receptors 2item
  163. CCL2 1 item
  164. 15-lipoxygenases 1 item
  165. AChE 1 item
  166. Insulin Receptors 1 item
  167. IRG-1R 1 item
  168. Inward Rectifier Potassium (Kir) Channels 1 item
  169. Arp2/3 complex 1 item
  170. Peptidoglycan synthesis 1 item
  171. Cdc7 1 item
  172. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  173. Aldosterone receptor 1 item
  174. Adenine receptors 1 item
  175. NAE 1 item
  176. Ubiquitin-activating Enzyme E1 1 item
  177. SUMOylation 1 item
  178. ATGL 1 item
  179. DPP-4 1 item
  180. DREADD Ligands 1 item
  181. PP4 1 item
  182. c-RET 1 item
  183. p53-MDM2 interaction 1 item
  184. Protein polybromo-1 1 item
  185. SMARCA4 1 item
  186. SMARCA2 1 item
  187. HDAC 1 item
  188. c-Fms tyrosine kinase 1 item
  189. human lyase 1 item
  190. Ub-conjugating enzyme (E2) complex 1 item
  191. IKK 1 item
  192. P97 ATPase 1 item
  193. NTPDases 1 item
  194. Rev-Erb Receptors 1 item
  195. DCLK2 1 item
  196. Lck 1 item
  197. NOP Receptors 1 item
  198. Bcl-w 1 item
  199. FXR 1 item
  200. Androgen Receptor 1 item
  201. Substance P/NK1 Receptor 1 item
  202. gp120/CD4 1 item
  203. ATM 1 item
  204. Sirtuin 1 item
  205. CRF1 Receptors 1 item
  206. PIKfyve 1 item
Reported Experiments
  1. Animal Experiments 304item
  2. Cell Experiments 196item
Related Disease
  1. Acute Kidney Injury 1 item
  2. Acute Myelogenous Leukemia 3item
  3. Acute Myeloid Leukemia 12item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Autoimmune Diseases 1 item
  6. Bladder Cancer 5item
  7. B-lymphoid Malignancies 1 item
  8. Breast Cancer 61item
  9. Cancer 182item
  10. Cervical Cancer 2item
  11. Cholangiocarcinoma 1 item
  12. Chronic Lymphocytic Leukemia 2item
  13. Colon Cancer 23item
  14. Colon Carcinoma 2item
  15. Colorectal Cancer 25item
  16. Diabetes 4item
  17. Dyskinesia 1 item
  18. Dyslipidemia 2item
  19. Erectile Dysfunction 1 item
  20. Friedreich's Ataxia 1 item
  21. Fungal Infection 1 item
  22. Glioblastoma 14item
  23. Glioma 6item
  24. Heart Failure 1 item
  25. Hepatocellular Carcinoma 3item
  26. HIV 3item
  27. HIV Infections 2item
  28. Immunosuppressive Therapy 1 item
  29. Inflammatory Diseases 10item
  30. Kidney Injury Studies 1 item
  31. Leukemia 8item
  32. Liver Cancer 3item
  33. Lung Cancer 16item
  34. Lymphoma 8item
  35. Mantle Cell Lymphoma 2item
  36. Medulloblastoma 1 item
  37. Melanoma 18item
  38. Mixed Lineage Leukemia 1 item
  39. Multiple Myeloma 11item
  40. Myelofibrosis 1 item
  41. Myeloma 1 item
  42. Narcolepsy 1 item
  43. Neuroblastoma 4item
  44. Non-small Cell Lung Cancer 10item
  45. Non-small Cell Lung Carcinoma 2item
  46. Ovarian Cancer 18item
  47. Pain Relief 1 item
  48. Pancreatic Cancer 20item
  49. Pancreatic Carcinoma 2item
  50. Prostate Cancer 27item
  51. Psoriasis 2item
  52. Pulmonary Arterial Hypertension 1 item
  53. Pulmonary Fibrosis 1 item
  54. Renal Cell Carcinoma 5item
  55. Rheumatoid Arthritis 3item
  56. Schizophrenia 2item
  57. Sleep Disorders 1 item
  58. Thyroid Cancer 2item
  59. Type 2 Diabetes 4item